Training on Using ıInsulin in Patients With Type 2 Diabetes

NCT05915338 | Completed

• 1 other identifier: INONU UNİV
• Study Type: observational
• Target: 84
• Locations: 1 country
• Sites: 1

Brief Summary

This study was conducted to evaluate the effect of individual insulin use training given to patients with type 2 diabetes using insulin on safe drug administration, pain level and perception of treatment. The study was conducted between October 2022 and March 2023 with a randomized control group.

Conditions

Insulin Dependent Diabetes; Diabetes type2

Keywords

Tip 2 Diyabet; Güvenli İlaç Kullanımı; Tedavi Algısı; İnsülin

Outcome Measures

Primary Outcomes (1)

• Fırst follow - up survey

  Pretest data was obtained using the introductory information form, IASOF, VAS, and ITES. Patients were requested to apply their daily dose of insulin to themselves and patients' application skills were recorded by the researchers into IASOF as the 1st observation.

  Fırst test-fırst applıcatıon both groups at the begınnıng of the research

Secondary Outcomes (1)

• Last test survey

  2 weeks after the fırst watch

Other Outcomes (1)

• Durabılıty test for both groups

  After 8 weeks, the follow-up test was done to both groups

Study Arms (2)

Experimental Group

-Pre-test data were obtained by using the descriptive information form, İUBGF, VAS, and HRAS. The patients were asked to self-administer a dose of insulin that day, and the ability of the patients to administer the insulin dose was recorded in the IUBGF as the 1st follow-up by the researchers. Afterwards, individual insulin use training was given and the "Educational Manual on the Use of Insulin for Individuals with Type 2 Diabetes" was given to the patients and the first follow-up was completed. -2 weeks later, post-test data were obtained from the patients using IUBGF, VAS, and HRAS. The ability of the patients to administer the insulin dose was recorded in the IUBGF as the second follow-up by the researchers. After 8 weeks, post-test data were obtained by using IUBGF, VAS, and HRAS as retention tests. The ability of the patients to administer the insulin dose was recorded by the researchers as the 3rd follow-up retention test in IUBGF.

Control Group

-Pre-test data were obtained by using the descriptive information form, İUBGF, VAS, and HRAS. The patients were asked to self-administer a dose of insulin that day, and the ability of the patients to administer the insulin dose was recorded in the IUBGF as the 1st follow-up by the researchers. -2 weeks later, post-test data were obtained from the patients using IUBGF, VAS, and HRAS. Patients were asked to self-administer a daily dose of insulin. The ability of the patients to administer the insulin dose was recorded in the IUBGF as the second follow-up by the researchers. After 8 weeks, post-test data were obtained by using IUBGF, VAS, and HRAS as retention tests. Patients were asked to self-administer a daily dose of insulin. The ability of the patients to administer the insulin dose was recorded in IUBGF as the 3rd follow-up retention test by the researchers.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients with Type 2 Diabetes

You may qualify if:

• Patients included in the study;
• years and over Using insulin injections for at least six months or longer
• Meeting the American Diabetes Association (ADA, 2021) diagnostic criteria for Type 2 diabetes
• No communication and mental problems
• Insulin injection made by himself or his family The patients who agreed to participate in the study.

You may not qualify if:

• Patients excluded from the study;
• Self or family member health personnel Those with advanced retinopathy, nephropathy, neuropathy
• Diagnosed with type 1 diabetes
• Pregnant or breastfeeding women
• Patients who participated in another clinical trial concurrently or within 1 month prior to the start of the trial.

Sponsors & Collaborators

• Inonu University: lead

Study Sites (1)

Şirnak Devlet Hastanesi

Şirnak, Merkez, 73000, Turkey (Türkiye)

Location

Related Publications (1)

• Ozturk MH, Kerkez M, Kilic SP. The power of insulin education: enhancing pain and treatment perception in adult type 2 diabetes patients. J Diabetes Metab Disord. 2025 Jun 5;24(1):140. doi: 10.1007/s40200-025-01652-2. eCollection 2025 Jun.

  PMID: 40485759 DERIVED

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Autoimmune Diseases; Immune System Diseases

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: OTHER
• Target Duration: 1 Month
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor Doctor

Study Record Dates

• First Submitted: June 9, 2023
• First Posted: June 23, 2023
• Study Start: October 1, 2022
• Primary Completion: January 5, 2023
• Study Completion: March 30, 2023
• Last Updated: June 26, 2023

Record last verified: 2023-06

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)